KT
Kevin Tan
CFO & Treasurer

Kevin Tan insider trades: Solid Biosciences (SLDB) stock buys and sales

CFO & Treasurer, Solid Biosciences Last trade Feb 18, 2026 14 Form 4 filings
$330K
Sold, last 12 months
4 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2021
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Kevin reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 18, 2026SLDB↓ Sell$31K
Feb 4, 2026SLDB↓ Sell$95K
Feb 2, 2026SLDB↓ Sell$173K
Jan 13, 2026SLDB↓ Sell$30K
Feb 14, 2025SLDB↓ Sell$13K
Jan 10, 2025SLDB↓ Sell$16K
Jan 9, 2024SLDB↓ Sell$32K
Dec 2, 2021SELB↑ Buy$15K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other SLDB insiders

Open-market trades in the last 12 months

About Kevin Tan's insider trades

Kevin Tan is CFO & Treasurer at Solid Biosciences (SLDB). Since Dec 2, 2021, Kevin has reported 1 open-market purchase worth $15K and 7 sales worth $390K on SEC Form 4. In the last 12 months: 4 sales ($330K).

Their filings also include grants and awards (7 filings), option exercises (6 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SLDB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.